# US 2008/0306435 A1 · Integrated medicament delivery device for use with continuous analyte sensor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306435 A1
- Document ID: US20080306435A1
- Status: Published application
- Kind: A1
- Application number: 12/133,786
- Filed: 2008-06-05
- Published: 2008-12-11
- Earliest claimed: 2007-06-08
- Assignees: DexCom, Inc.
- Inventors: Apurv U. Kamath; Richard C. Yang; Jacob S. Leach; Nelson Quintana
- Web page: https://patentgrep.com/patent/US20080306435A1

## CPC

- G06T 11/26: Drawing of charts or graphs
- A61B 5/0002: {Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network (endoradiosondes A61B5/07)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- A61B 5/4839: {combined with drug delivery}
- A61M 5/24: Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or cartridges, e.g. automatic
- A61M 5/31525: {Dosing (burettes, pipettes B01L3/02)}
- A61B 2560/0406: specially shaped apparatus housings
- A61B 2560/0431: Portable apparatus, e.g. comprising a handle or case
- A61B 2560/0443: Modular apparatus
- A61M 5/003: {Kits for diabetics}
- A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body}
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61M 5/3129: {Syringe barrels (A61M5/3205, A61M5/50 take precedence)}
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A61M 2209/086: Docking stations
- G06T: IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

## Claims

### Claim 1

An integrated system for monitoring and treating diabetes, the system comprising:
a receiver configured and arranged to receive continuous glucose sensor data from a continuous glucose sensor;
a processor module configured to process the continuous glucose sensor data and to provide first and second medicament dosing information based at least in part on the continuous glucose sensor data; and
a communication module configured and arranged to communicate the medicament dosing information with a first integrated medicament delivery device and a second integrated medicament delivery device.

### Claim 2 (depends on 1)

The integrated system of claim 1, wherein the first medicament dosing information comprises a basal medicament dose and the first integrated medicament delivery device comprises a basal medicament delivery device.

### Claim 3 (depends on 2)

The integrated system of claim 2, wherein the basal medicament delivery device comprises a medicament pump configured to infuse a first medicament.

### Claim 4 (depends on 2)

The integrated system of claim 2, wherein the processor module comprises programming to calculate a basal dose based at least in part on the continuous glucose sensor data.

### Claim 5 (depends on 2)

The integrated system of claim 2, wherein the second medicament dosing information comprises a bolus medicament dose and the second integrated medicament delivery device comprises a bolus medicament delivery device.

### Claim 6 (depends on 5)

The integrated system of claim 5, wherein the processor module comprises programming to calculate a bolus dose based at least in part on the continuous glucose sensor data.

### Claim 7 (depends on 5)

The integrated system of claim 5, wherein the bolus medicament delivery device comprises a hand-held medicament injection pen configured to infuse a second medicament.

### Claim 8 (depends on 5)

The integrated system of claim 5, wherein the bolus medicament delivery device comprises a motor configured to automatically set the amount of medicament and the medicament dosing information comprises an instruction for the medicament delivery device to automatically portion out the bolus dose, whereby the portioned out bolus dose can be manually delivered by the host.

### Claim 9 (depends on 5)

The integrated system of claim 5, wherein the bolus medicament delivery device comprises a motor to control a rate of medicament injection into the host.

### Claim 10 (depends on 1)

The integrated system of claim 1, further comprising a user interface configured and arranged to display at least one of continuous glucose sensor data and medicament dosing information.

### Claim 11 (depends on 10)

The integrated system of claim 10, wherein the user interface is further configured for input of at least one of host information and medicament delivery device information.

### Claim 12 (depends on 11)

The integrated system of claim 11, wherein the host information comprises at least one of host identity, host physical state, target glucose concentration and type of medicament to be delivered.

### Claim 13 (depends on 11)

The integrated system of claim 11, wherein the medicament delivery information comprises at least one of host identity, identification of a functionally connected medicament delivery device, a type of medicament to be delivered, a medicament delivery profile, a medicament delivery protocol, and a failsafe.

### Claim 14 (depends on 1)

The integrated system of claim 1, wherein the communication module comprises a communication module configured and arranged to interrogate and/or provide medicament dosing information to the first medicament delivery device and the second medicament delivery device.

### Claim 15 (depends on 1)

The integrated system of claim 1, wherein the receiver comprises the communication module and the processor module, and wherein the receiver wirelessly communicates with the first and second medicament delivery devices.

### Claim 16 (depends on 1)

The integrated system of claim 1, wherein the receiver comprises the communication module and the processor module, and wherein the receiver is physically connected to at least one of the first medicament delivery device and the second medicament delivery device.

### Claim 17

A method of self-monitoring and self-treating diabetes, the method comprising:
receiving continuous glucose sensor data from an operably connected continuous glucose sensor;
processing the continuous glucose sensor data;
calculating medicament dosing information for at least two integrated medicament delivery devices based at least in part on the continuous glucose sensor data; and
communicating the medicament dosing information with the integrated medicament delivery devices.

### Claim 18 (depends on 17)

The method of claim 17, wherein the step of calculating medicament dosing information comprises calculating a basal dose based at least in part on the continuous glucose sensor data.

### Claim 19 (depends on 18)

The method of claim 18, wherein the step of communicating comprises communicating the basal medicament dose to a medicament pump.

### Claim 20 (depends on 19)

The method of claim 19, further comprising infusing the basal medicament dose.

### Claim 21 (depends on 17)

The method of claim 17, wherein the step of providing medicament dosing information comprises calculating a bolus dose based at least in part on the continuous glucose sensor data.

### Claim 22 (depends on 21)

The method of claim 21, wherein the step of communicating comprises communicating the bolus medicament dose to a hand-held injector pen.

### Claim 23 (depends on 22)

The method of claim 22, wherein the step of delivering comprises injecting the bolus medicament dose.

### Claim 24 (depends on 23)

The method of claim 23, wherein the step of communicating the bolus dose further comprises providing an instruction to automatically set at least one of the amount of medicament and rate of delivery based at least in part on the medicament dosing information.

### Claim 25 (depends on 24)

The method of claim 24, wherein the step of delivering the bolus dose further comprises automatically setting the amount of medicament based at least in part on the provided instruction.

### Claim 26 (depends on 24)

The method of claim 24, wherein the step of delivering the bolus dose further comprises automatically setting the rate of delivery based at least in part on the provided instruction.

### Claim 27 (depends on 17)

The method of claim 17, further comprising displaying at least one of continuous glucose sensor data and medicament dosing information.

### Claim 28 (depends on 17)

The method of claim 17, further comprising inputting at least one of host information and medicament delivery device information.

### Claim 29 (depends on 17)

The method of claim 17, wherein the step of communicating comprises wirelessly communicating.

### Claim 30 (depends on 29)

The method of claim 29, wherein the step of wirelessly communicating comprises interrogating and/or providing medicament dosing information.
